Myron Evans

Dr. Myron Evans is an Assistant Professor in the Department of Pediatrics at the University of Washington School of Medicine, where he leads the Myron Evans Lab at the Ben Towne Center for Childhood Cancer and Blood Disorders Research. His laboratory focuses on understanding the molecular mechanisms behind pediatric brain tumors, with particular emphasis on medulloblastoma, diffuse midline glioma, and atypical teratoid/rhabdomyosarcoma tumor.

Dr. Evans' research spans developmental neurobiology and cancer genomics, investigating how normal brain development pathways become hijacked in tumor formation. His work employs cutting-edge molecular tools including single-cell sequencing, functional genomics, and spatial transcriptomics to identify novel therapeutic targets. Key areas of investigation include the role of YBX1 in postnatal brain development and oncogene-dependent vulnerabilities in aggressive medulloblastoma subtypes.

His publication record demonstrates expertise across multiple cancer types, with recent work focusing on pediatric brain tumors but earlier contributions to breast cancer research. The research trends show a progression from fundamental cancer biology toward increasingly specialized work in pediatric neuro-oncology, particularly exploring epigenetic mechanisms as therapeutic targets.

Dr. Evans received his PhD in experimental pathology from Duke University under Dr. Gayathri Devi and completed postdoctoral training at St. Jude Children's Research Hospital with Drs. Jamy Peng and Mark Hatley. His laboratory collaborates with clinical teams on translational projects, including work related to the BrainChild-01 clinical trial that uses CAR T-cell therapy for pediatric brain tumors.